Treatment of Kleptomania
Cognitive-behavioral therapy (CBT) with exposure and response prevention (ERP) combined with a selective serotonin reuptake inhibitor (SSRI) is the first-line treatment for kleptomania. This approach addresses both the compulsive nature of the disorder and the underlying serotonergic dysfunction.
First-Line Treatment Options
- SSRIs (fluoxetine, paroxetine) have demonstrated effectiveness in treating kleptomania by addressing the serotonergic dysfunction that appears to underlie the disorder 1
- CBT with exposure and response prevention techniques should be implemented alongside medication, similar to treatment approaches for obsessive-compulsive spectrum disorders 2
- Psychoeducation for both patients and family members is essential to address stigma, improve understanding of the condition, and enhance treatment adherence 2
Pharmacological Treatment Algorithm
First-Line:
- Begin with an SSRI (fluoxetine or paroxetine) at standard doses for 8-12 weeks to determine efficacy 1
- If partial response, continue treatment for at least 12-24 months after achieving symptom reduction to prevent relapse 2
Second-Line (for inadequate response):
- Consider switching to a different SSRI or increasing to higher doses 2
- Augmentation strategies may include:
Third-Line:
- For treatment-resistant cases, consider glutamatergic agents (memantine, topiramate) as augmentation 2
- In severe cases with significant functional impairment, specialized treatment providers should be consulted 2
Psychotherapeutic Approaches
- CBT with ERP should focus on:
- Motivational interviewing techniques can help build therapeutic alliance and address poor insight or treatment resistance 2
- Group therapy may provide additional support and reduce stigma 2
Treatment Considerations for Special Populations
- For patients with comorbid mood disorders (especially bipolar disorder):
- For patients with legal complications:
Monitoring and Maintenance
- Use standardized measures like the Yale-Brown Obsessive Compulsive Scale as a surrogate marker to gauge response to treatment 5
- Regular monitoring for symptom recurrence, especially during periods of stress or when comorbid conditions worsen 6
- Maintenance treatment should continue for at least 12-24 months after achieving remission to prevent relapse 2
Common Pitfalls and Caveats
- Kleptomania is often underdiagnosed and undertreated, with many patients seeking help only after legal consequences 6
- Patients may not disclose stealing behaviors due to shame and stigma, requiring sensitive screening approaches 6
- Comorbid conditions (especially depression) are common and may require simultaneous treatment 7
- Discontinuation of medication can lead to rapid resurgence of kleptomanic behavior 1
- Treatment should not be limited to addressing the stealing behavior but should also focus on improving overall functioning and quality of life 4